Pharmabiz17h
EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples
EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...
EU Medicines Agency assesses first AI diagnosis as "scientifically valid"
For the first time, the European Medicines Agency has recognized AI software for the diagnosis of fatty liver hepatitis as ...
NL Times1d
European Medicines Agency gives first green light to AI use citing liver biopsy trial
The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...
pharmaphorum1d
EMA panel endorses AI for MASH clinical trials
AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...
EU health regulator clears use of AI tool in fatty liver disease trials
A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH ...
Inflammation and Scarring of the Bile Ducts: Causes, Diagnosis, and Treatments
Bile duct inflammation and scarring, known as cholangiopathies, can disrupt bile flow, leading to liver damage and ...